CCND3 and breast carcinoma: Using two breast cancer cell lines (i.e. MCF-7 and MDA-MB-231), Tsai et al., (2007) demonstrated that DHTS significantly inhibits the proliferation of breast cancer cells by modulating the cell cycle genes i.e. cyclin D1, cyclin D3, cyclin E, and CDK4.